UY39111A - Compuestos para su uso en afecciones autoinmunitarias - Google Patents

Compuestos para su uso en afecciones autoinmunitarias

Info

Publication number
UY39111A
UY39111A UY0001039111A UY39111A UY39111A UY 39111 A UY39111 A UY 39111A UY 0001039111 A UY0001039111 A UY 0001039111A UY 39111 A UY39111 A UY 39111A UY 39111 A UY39111 A UY 39111A
Authority
UY
Uruguay
Prior art keywords
compounds
autoimmune diseases
treatment
rheumatoid arthritis
relates
Prior art date
Application number
UY0001039111A
Other languages
English (en)
Inventor
Avilés Marín Pablo
Losada González Alejandro
Original Assignee
Pharma Mar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa
Publication of UY39111A publication Critical patent/UY39111A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Transplantation (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se refiere al uso de compuestos en el tratamiento de afecciones autoinmunitarias y en particular, para el tratamiento de la artritis reumatoide.
UY0001039111A 2020-03-02 2021-03-02 Compuestos para su uso en afecciones autoinmunitarias UY39111A (es)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
EP20382152 2020-03-02
EP20382192 2020-03-13
EP20382266 2020-04-02
EP20382339 2020-04-27
EP20382815 2020-09-16
EP20382814 2020-09-16
EP21382059 2021-01-25

Publications (1)

Publication Number Publication Date
UY39111A true UY39111A (es) 2021-09-30

Family

ID=74732952

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001039111A UY39111A (es) 2020-03-02 2021-03-02 Compuestos para su uso en afecciones autoinmunitarias

Country Status (16)

Country Link
US (1) US20230158104A1 (es)
EP (1) EP4114432A1 (es)
JP (1) JP2023517537A (es)
KR (1) KR20220148896A (es)
CN (1) CN115867286A (es)
AU (1) AU2021229592A1 (es)
BR (1) BR112022017129A2 (es)
CA (1) CA3169557A1 (es)
CL (1) CL2022002397A1 (es)
CO (1) CO2022014023A2 (es)
IL (1) IL296070A (es)
MX (1) MX2022010925A (es)
PE (1) PE20231101A1 (es)
TW (1) TW202146039A (es)
UY (1) UY39111A (es)
WO (1) WO2021175829A1 (es)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8922026D0 (en) * 1989-09-29 1989-11-15 Pharma Mar Sa Novel anti-viral and cytotoxic agent
US6156724A (en) * 1996-06-07 2000-12-05 Rinehart; Kenneth L. Uses of didemnins as immunomodulating agents
GB9803448D0 (en) 1998-02-18 1998-04-15 Pharma Mar Sa Pharmaceutical formulation
JP2003535048A (ja) 2000-04-07 2003-11-25 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア タマンダリンおよびジデムニン同族体およびそれらの作成および使用法
UA76718C2 (uk) 2000-06-30 2006-09-15 Фарма Мар, С.А. Протипухлинні похідні аплідину
EP1613338A4 (en) 2003-03-21 2009-06-24 Madeleine M Joullie TAMANDARIN ANALOGUES, FRAGMENTS THEREOF AND METHODS OF MAKING AND USING THE SAME
WO2011020913A2 (en) 2009-08-21 2011-02-24 Pharma Mar, S.A. Cyclodepsipeptide antiviral compounds

Also Published As

Publication number Publication date
CL2022002397A1 (es) 2023-06-30
US20230158104A1 (en) 2023-05-25
CA3169557A1 (en) 2021-09-10
AU2021229592A1 (en) 2022-09-29
TW202146039A (zh) 2021-12-16
KR20220148896A (ko) 2022-11-07
BR112022017129A2 (pt) 2022-10-11
CO2022014023A2 (es) 2022-11-18
WO2021175829A1 (en) 2021-09-10
PE20231101A1 (es) 2023-07-18
IL296070A (en) 2022-11-01
MX2022010925A (es) 2022-09-29
EP4114432A1 (en) 2023-01-11
JP2023517537A (ja) 2023-04-26
CN115867286A (zh) 2023-03-28

Similar Documents

Publication Publication Date Title
CO2021005987A2 (es) Compuestos de anillo fusionado
CO2021003036A2 (es) Compuestos de anillo fusionado
CL2018001512A1 (es) Anticuerpos anti-cd73 humanizados.
DOP2021000132A (es) Inhibidores de il-17a
CR20180029A (es) Inhibidores peotídicos del receptor de interleucina 23 y su uso para tratar enfermedades inflamatorias
CL2021001471A1 (es) Composición novedosa
CL2018000107A1 (es) Moléculas de anticuerpo que se unen a cd79
CL2009000618A1 (es) Uso de anticuerpo monoclonal humanizado th1, que reconoce el dominio 1 del cd6 humano, para preparar un medicamento útil en el tratamiento de la diabetes tipo-1.
CL2018000108A1 (es) Moléculas de anticuerpo que se unen a cd22
CL2012001627A1 (es) Compuestos derivados de 1,3-tiazol-fenilaminopirimidinas, inhibidores de syk; composición farmacéutica; y su uso para el tratamiento de la artritis reumatoide y cancer.
CL2018000106A1 (es) Moléculas de anticuerpo que se unen a cd45
UY34387A (es) Composiciones para el tratamiento de la artritis reumatoide y métodos para su utilización.
AR114283A1 (es) Receptores quiméricos de dll3 y métodos para su uso
CL2009000650A1 (es) Compuestos derivados de amino-pirazina, inhibidores de cinasa-pi 3; composicion farmaceutica; y uso para el tratamiento de condiciones inflamatorias o alérgicas, tales como enfermedades respiratorias, artritis reumatoide, colitis ulcerativa, entre otras
CL2019002127A1 (es) Método de reducción de la neutropenia.
CL2010001641A1 (es) Compuestos derivados de heterociclos biciclicos sustituidos; composicion farmaceutica; y su uso como inhibidores de la quinasa mek para tratar enfermedades hiperproliferativas e inflamatorias tales como cancer y artritis reumatoide entre otras.
UY38739A (es) Proteínas multiespecíficas
ECSP10010475A (es) Derivados de azetidina y ciclobutano como inhibidores de jak
CO2022002622A2 (es) Anticuerpos anti-cd73 y composiciones
BR112022000328A2 (pt) Inibidores peptídicos do receptor de interleucina-23 e seu uso para tratar doenças inflamatórias
EA201290360A1 (ru) Гуманизированные антитела против il-22ra человека
CO6561811A2 (es) Composiciones de etanol
CL2021002318A1 (es) Métodos de tratamiento de amiloidosis al
EA202191983A1 (ru) МОДУЛЯТОРЫ mTORC И ИХ ПРИМЕНЕНИЕ
BR112018067851A2 (pt) composições e métodos para o tratamento de artrite reumatoide